As of 2026-08-18, the Intrinsic Value of BetterLife Pharma Inc (BETR.CN) is -0.04 CAD. This BETR.CN valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.28 CAD, the upside of BetterLife Pharma Inc is -115.39%.
Based on its market price of 0.28 CAD and our intrinsic valuation, BetterLife Pharma Inc (BETR.CN) is overvalued by 115.39%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -0.04 - -0.04 | -0.04 | -115.39% |
| DDM - Stable | (0.09) - (0.29) | (0.19) | -165.9% |
| DDM - Multi | (0.12) - (0.32) | (0.17) | -161.2% |
| Market Cap (mil) | 61.52 |
| Beta | 0.18 |
| Outstanding shares (mil) | 215.85 |
| Enterprise Value (mil) | 62.11 |
| Market risk premium | 5.10% |
| Cost of Equity | 8.92% |
| Cost of Debt | 5.00% |
| WACC | 8.85% |